Cargando…
Anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797336/ https://www.ncbi.nlm.nih.gov/pubmed/35117070 http://dx.doi.org/10.21037/tcr.2018.08.21 |
| _version_ | 1784641525898018816 |
|---|---|
| author | Furukawa, Koichi Ohmi, Yuhsuke Furukawa, Keiko |
| author_facet | Furukawa, Koichi Ohmi, Yuhsuke Furukawa, Keiko |
| author_sort | Furukawa, Koichi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8797336 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87973362022-02-02 Anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas Furukawa, Koichi Ohmi, Yuhsuke Furukawa, Keiko Transl Cancer Res Editorial AME Publishing Company 2019-03 /pmc/articles/PMC8797336/ /pubmed/35117070 http://dx.doi.org/10.21037/tcr.2018.08.21 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Editorial Furukawa, Koichi Ohmi, Yuhsuke Furukawa, Keiko Anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas |
| title | Anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas |
| title_full | Anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas |
| title_fullStr | Anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas |
| title_full_unstemmed | Anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas |
| title_short | Anti-GD2 CAR T cells could prove transformative for H3-K27M(+) diffuse midline gliomas |
| title_sort | anti-gd2 car t cells could prove transformative for h3-k27m(+) diffuse midline gliomas |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797336/ https://www.ncbi.nlm.nih.gov/pubmed/35117070 http://dx.doi.org/10.21037/tcr.2018.08.21 |
| work_keys_str_mv | AT furukawakoichi antigd2cartcellscouldprovetransformativeforh3k27mdiffusemidlinegliomas AT ohmiyuhsuke antigd2cartcellscouldprovetransformativeforh3k27mdiffusemidlinegliomas AT furukawakeiko antigd2cartcellscouldprovetransformativeforh3k27mdiffusemidlinegliomas |